Expert perspectives on the nature and occurrence of graft-versus-host disease alongside available prophylactic regimens.
Graft versus Host Disease Practice Updates
Centering discussion on a patient scenario of acute graft-versus-host disease, participants discuss nuance in disease symptomology and patient education.
A panel of experts discuss systemic therapy to manage a patient with acute graft-versus-host disease.
Experts review the prognosis of a patient with acute graft-versus-host disease and identify ways to optimize their treatment strategies.
Shifting their focus to chronic graft-versus-host disease, experts review a patient scenario and discuss the challenges in early intervention.
Shared insight on how to distinguish chronic GVHD from acute GVHD, as well as utilize appropriate methods to risk stratify disease.
A review of treatment options approved for steroid-refractory chronic graft-versus-host disease starting with ibrutinib and ruxolitinib.
Considerations for belumosudil and axatilimab as treatment options for steroid-refractory chronic graft-versus-host disease.
Having reviewed approved treatment options for steroid-refractory, chronic GVHD, experts discuss how they would address this patient scenario.
A brief discussion on the risk of treatment-induced damage when managing patients with chronic graft-versus-host disease.
Closing out their discussion on graft-versus-host disease, participants reflect on patient prognoses and the future directions of care.